"Recommendations for evaluating compliance and persistence with hyperte" by Michael T. Halpern, Zeba M. Khan et al.

Meyers Primary Care Institute Publications and Presentations

Title

Recommendations for evaluating compliance and persistence with hypertension therapy using retrospective data

Authors

Michael T. Halpern, Exponent
Zeba M. Khan, Novartis Pharma AG
Jordana K. Schmier, Exponent
Michel Burnier, University of Lausanne
J. Jaime Caro, Caro Research
Joyce Cramer, Yale University
William L. Daley, Novartis Pharmaceuticals Corporation
Jerry H. Gurwitz, University of Massachusetts Medical SchoolFollow
Norman K. Hollenberg, Harvard University

UMMS Affiliation

Meyers Primary Care Institute; Department of Medicine, Division of Geriatric Medicine

Date

6-1-2006

Document Type

Article

Medical Subject Headings

Behavioral Research; Humans; Hypertension; *Patient Compliance; Retrospective Studies

Disciplines

Health Services Research | Primary Care

Abstract

Hypertension is a major risk factor for cardiovascular and cerebrovascular disease. The associated economic burden of hypertension is also substantial. Given the importance of this issue, we have developed a set of recommendations for retrospective studies assessing compliance and persistence in hypertension.